Goldline Pharmaceutical IPO Allotment Status (Check Online)

Goldline Pharmaceutical Limited IPO

BSE SME Allotment Awaited

The Goldline Pharmaceutical IPO allotment status is likely to be announced today (May 15, 2026). After the allotment is finalized, investors can check their status online using PAN, application number, or DP client ID on IPO Ji or the registrar website.

Check IPO allotment status by PAN, Application Number or DP ID.

₹2,58,000 (6000 Shares)
Minimum Investment
IPO Dates
May 12, 2026 – May 14, 2026
Price band
₹41-43 per equity share
Minimum Investment
₹2,58,000
Issue size
₹11.61 Cr
Lot size
3000
Allotment Date
May 15, 2026
Listing
May 19, 2026
Listing At
BSE SME

IPO timeline

  1. May 12, 2026

    Open Date

    Completed

  2. May 14, 2026

    Close Date

    Completed

  3. May 15, 2026

    Allotment Date

    Current

  4. May 19, 2026

    Listing Date

    Upcoming

Goldline Pharmaceutical IPO Details

Issue Price
₹41-43 per equity share
Face Value
₹10 Per Equity Share
Lot Size
3000
Listing At
BSE SME
Registrar
Bigshare Services Pvt.Ltd.
How to Check Under a minute

Check your IPO allotment instantly

See if you got shares in any IPO — all from one place.

  1. Log in to your account
  2. Select the IPO from the dropdown
  3. Tap Check Allotment
Watch Video

Status appears instantly once allotment is published.

How to check IPO allotment – video thumbnail
1M+ Checks done
All IPOs Covered
Instant Results

Allotment Overview

The allotment for the initial public offer (IPO) of Goldline Pharmaceutical Limited IPO is being finalized today, May 15, 2026. Investors can check their allotment status on the issue's registrar Bigshare Services Pvt Ltd website, IPO Ji app/website, as well as on the BSE and NSE websites.

Subscription Details

The Goldline Pharmaceutical Limited IPO was open for subscription between May 12, 2026 - May 14, 2026 at a price band in the range of ₹41-43 per equity share.

Subscription response by investor category

The Goldline Pharmaceutical Limited IPO's initial public offering received good responses from investors throughout the three-day bidding. Retail investors' portion was subscribed 881.15 times, while non-institutional investors' quota received 1662.39 times subscription. The qualified institutional buyers (QIBs) portion was booked 180.22 times. Overall, the IPO was subscribed 840.81 times.

Check Full Subscription Details about Goldline Pharmaceutical Limited IPO
180.22x
QIB
1662.39x
Non-Institutional
881.15x
Retail Investors
840.81x
Total

How to Check Goldline Pharmaceutical Limited IPO Allotment Status Online

You can check your IPO allotment status online on the website of the IPO registrar, IPO Ji App/Website, and BSE and NSE websites. You can check the allotment status of the Goldline Pharmaceutical Limited IPO if you have applied for it.

Steps to Check Goldline Pharmaceutical Limited IPO Allotment on Bigshare Services Pvt Ltd's Website:

1 Go to Bigshare Services Pvt Ltd IPO page.
2 Choose Goldline Pharmaceutical Limited IPO from the list.
3 Pick either PAN (Permanent Account Number), Demat Account number, or Application number.
4 Fill in the details based on your selected mode.
5 Enter the captcha code.
6 Click on the "Submit" button to view your allotment status.

Steps to Check Goldline Pharmaceutical Limited IPO Allotment Status on IPO Ji App/Website:

1 Launch the IPO Ji app on your mobile device or visit ipoji.com
2 Navigate to the IPO Allotment Page directly from the home screen of the App or by clicking here (www.ipoji.com/ipo-allotment-status).
3 Create your free account by Providing your PAN and Demat details. (one-time process)
4 Choose Goldline Pharmaceutical Limited IPO from the list of available IPOs.
5 Click on the Check Status button.
6 Your allotment status will be displayed on the screen.

Allotment status on BSE and NSE

How to Check Goldline Pharmaceutical Limited IPO Allotment on BSE:
2 Choose Equity under the "Issue Type" dropdown.
3 Choose Goldline Pharmaceutical Limited IPO from the "Issue Name" dropdown.
4 Provide your Application Number and PAN ID.
5 Tick the 'I am not a robot' box.
6 Click on the "Search" button to view your status.

Contact Information

On securing the allotment, you will receive the credit of equivalent shares in your Demat account.

If you have any concerns or queries about the allotment status, contact Bigshare Services Pvt Ltd either by phone or email. Investors can call on +91-22-6263 8200 or send an email with all relevant details to ipo@bigshareonline.com.

+91-22-6263 8200
ipo@bigshareonline.com

Frequently Asked Questions

Click any question to reveal the answer

Goldline Pharmaceutical IPO allotment status is expected to be finalised today, May 15, 2026.

You can check the Goldline Pharmaceutical IPO allotment status online using PAN, Application Number, or DP Client ID:

  • Open the Goldline Pharmaceutical IPO allotment status page on IPO Ji.
  • Click Allotment Status.
  • Enter your PAN, Application Number, or DP Client ID.
  • Click Search to view your result.

Sample allotment result format:

  • PAN No.: ABCTY1234D
  • Application No.: 9876543210
  • Name: Rakesh J
  • Shares Applied: 50
  • Shares Allotted: 50

There is no fixed or guaranteed expected listing price for the Goldline Pharmaceutical IPO. The listing price depends on overall market conditions, investor demand, and the company’s fundamentals. The grey market premium (GMP) can indicate market sentiment, but the actual listing price may be higher or lower than GMP expectations.

You can check the Goldline Pharmaceutical IPO allotment status on IPO Ji and on the registrar’s official website (Bigshare Services Pvt.Ltd.) once the allotment is published.

The allotment is expected on May 15, 2026.

If the Goldline Pharmaceutical IPO is oversubscribed in the retail category, shares are allotted to Retail Individual Investors (RII) as per the allotment rules. Typically, investors may receive a minimum of 1 lot, subject to availability in the retail portion. If there are not enough shares to allot at least 1 lot to everyone, a lottery is conducted to decide the allotment.

The Goldline Pharmaceutical IPO listing date is May 19, 2026. The equity shares are expected to list on BSE SME.

Common reasons for not getting allotment in the Goldline Pharmaceutical IPO include:

  • Oversubscription: If the retail category is oversubscribed, allotment is done through a lottery, so many valid applications may not get shares.
  • UPI mandate / payment issue: The UPI mandate was not approved in time, or funds were not blocked successfully.
  • Application issue: The application may be rejected due to incorrect or mismatched details (PAN, DP ID/Client ID), or duplicate applications from the same PAN.
  • Bid issue (Retail/RII): If you applied in the retail category and did not bid at the cut-off price, and your bid price was below the final issue price, your application may not be considered.

The registrar for the Goldline Pharmaceutical IPO is Bigshare Services Pvt.Ltd..

If you don’t receive allotment in the Goldline Pharmaceutical IPO, the blocked amount (UPI mandate/ASBA) is usually released after the allotment is finalised. In most cases, it is unblocked within 24 hours, but it may take up to 1–2 working days depending on your bank.

If you are allotted shares, the required amount is debited from your bank account and the remaining balance (if any) is unblocked.